Marburg, Germany

Udo Krupka

This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignees: Dade Behring Marburg Gmbh, Siemens Healthcare Diagnostics Products Gmbh, Troponwerke Gmbh & Co Kg. Active years: 1986-2014.


% Patents Active = 66.7


Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1986-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Udo Krupka: Innovator in Hepatitis B Research

Introduction

Udo Krupka is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of medical research, particularly in the study of the hepatitis B virus. With a total of 6 patents to his name, Krupka's work has had a substantial impact on diagnostics and treatment methodologies.

Latest Patents

Among his latest patents is a groundbreaking invention related to a surface protein (HBsAg) variant of the hepatitis B virus. This invention pertains to sequences of a novel variant of the Hepatitis B surface antigen (HBsAg) and outlines methods for detecting nucleic acids, antigens, and antibodies in patient samples. This advancement is crucial for improving diagnostic accuracy and patient care.

Career Highlights

Throughout his career, Udo Krupka has worked with prominent companies in the healthcare sector. Notably, he has been associated with Dade Behring Marburg GmbH and Siemens Healthcare Diagnostics Products GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical diagnostics.

Collaborations

Krupka has collaborated with esteemed colleagues, including Wolfgang Schmandt and Wolfgang Opitz. These partnerships have fostered a collaborative environment that has been essential for advancing his research and inventions.

Conclusion

Udo Krupka's contributions to hepatitis B research and diagnostics exemplify the importance of innovation in healthcare. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…